UNLABELLED: Myoglobinuria is a frequent complication of metabolic myopathies and may also occur in Duchenne and Becker dystrophies but is not a typical sign of limb-girdle muscular dystrophy. We describe an unusual presentation of alpha-sarcoglycanopathy with myoglobinuria at the onset of the disease. The boy presented an episode of dark urine, identified as presence of blood by a urine dipstick, occurred 10 days after an episode of fever and sore throat treated with antibiotics. He was admitted to the hospital and investigated for post-infectious nephritis, but further analysis revealed the presence of myoglobinuria. Immunohistochemistry on muscle tissue revealed absent expression of α-sarcoglycan confirmed by detection of a homozygous mutation in the alpha-sarcoglycan gene. Myoglobinuria has been previously reported four times in sarcoglycanopathies but only once in alpha-sarcoglycanopathy. CONCLUSION: The present observation reinforces the idea that the myoglobinuria should be considered a manifestation of a primary sarcoglycanopathy even as the only recognizable sign at the debut of the disease.
UNLABELLED: Myoglobinuria is a frequent complication of metabolic myopathies and may also occur in Duchenne and Becker dystrophies but is not a typical sign of limb-girdle muscular dystrophy. We describe an unusual presentation of alpha-sarcoglycanopathy with myoglobinuria at the onset of the disease. The boy presented an episode of dark urine, identified as presence of blood by a urine dipstick, occurred 10 days after an episode of fever and sore throat treated with antibiotics. He was admitted to the hospital and investigated for post-infectious nephritis, but further analysis revealed the presence of myoglobinuria. Immunohistochemistry on muscle tissue revealed absent expression of α-sarcoglycan confirmed by detection of a homozygous mutation in the alpha-sarcoglycan gene. Myoglobinuria has been previously reported four times in sarcoglycanopathies but only once in alpha-sarcoglycanopathy. CONCLUSION: The present observation reinforces the idea that the myoglobinuria should be considered a manifestation of a primary sarcoglycanopathy even as the only recognizable sign at the debut of the disease.
Authors: R Barresi; V Confalonieri; M Lanfossi; C Di Blasi; E Torchiana; R Mantegazza; L Jarre; N Nardocci; P Boffi; F Tezzon; A Pini; F Cornelio; M Mora; L Morandi Journal: Acta Neuropathol Date: 1997-07 Impact factor: 17.088
Authors: R Cagliani; G P Comi; L Tancredi; M Sironi; F Fortunato; R Giorda; A Bardoni; M Moggio; A Prelle; N Bresolin; G Scarlato Journal: Neuromuscul Disord Date: 2001-05 Impact factor: 4.296
Authors: Ana F B Ferreira; Mary S Carvalho; Maria Bernadete D Resende; Alda Wakamatsu; Umbertina Conti Reed; Suely Kazue Nagahashi Marie Journal: Clinics (Sao Paulo) Date: 2011 Impact factor: 2.365
Authors: Jerry R Mendell; Louis G Chicoine; Samiah A Al-Zaidy; Zarife Sahenk; Kelly Lehman; Linda Lowes; Natalie Miller; Lindsay Alfano; Beverly Galliers; Sarah Lewis; Darren Murrey; Ellyn Peterson; Danielle A Griffin; Kathleen Church; Sharon Cheatham; John Cheatham; Mark J Hogan; Louise R Rodino-Klapac Journal: Hum Gene Ther Date: 2019-04-19 Impact factor: 5.695
Authors: Renata Siciliani Scalco; Alice R Gardiner; Robert Ds Pitceathly; Edmar Zanoteli; Jefferson Becker; Janice L Holton; Henry Houlden; Heinz Jungbluth; Ros Quinlivan Journal: Orphanet J Rare Dis Date: 2015-05-02 Impact factor: 4.123
Authors: James R Mickelson; Katie M Minor; Ling T Guo; Steven G Friedenberg; Jonah N Cullen; Amanda Ciavarella; Lydia E Hambrook; Karen M Brenner; Sarah E Helmond; Stanley L Marks; G Diane Shelton Journal: Skelet Muscle Date: 2021-01-07 Impact factor: 4.912
Authors: N Kruijt; L R van den Bersselaar; E J Kamsteeg; W Verbeeck; M M J Snoeck; D S Everaerd; W F Abdo; D R M Jansen; C E Erasmus; H Jungbluth; N C Voermans Journal: Eur J Neurol Date: 2020-10-25 Impact factor: 6.089